Australia markets open in 6 hours 21 minutes

Establishment Labs Holdings Inc. (ESTA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
70.79+0.79 (+1.13%)
As of 12:39PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close70.00
Open70.98
Bid70.58 x 800
Ask70.85 x 800
Day's range69.80 - 70.98
52-week range44.03 - 93.80
Volume51,356
Avg. volume118,857
Market cap1.729B
Beta (5Y monthly)1.03
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Establishment Labs to Present at the Cowen 43rd Annual Health Care Conference

    NEW YORK, February 28, 2023--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that Juan José Chacón-Quirós, Founder and Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, will present at the Cowen 43rd Annual Health Care Conference on Tuesday, March 7, 2023, at 9:50 am Eastern Time.

  • Business Wire

    Establishment Labs Submits Module Four to U.S. FDA for Premarket Approval of Motiva and Reports Record Fourth Quarter and Full Year 2022 Financial Results

    NEW YORK, February 27, 2023--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced that it has submitted the fourth and final module of its modular submission to the FDA for premarket approval of Motiva Implants® in the United States. The company also provided unaudited financial results for the fourth quarter and full year ended December 31, 202

  • Business Wire

    Establishment Labs to Announce Fourth Quarter 2022 Financial Results on February 27

    SANTA BARBARA, Calif., February 13, 2023--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended December 31, 2022, after the market closes on Monday, February 27, 2023, and will host a conference call at 4:30 pm ET that day to discuss those results.